| RS786205068 |
BSCL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital generalized lipodystrophy type 2, Berardinelli-Seip congenital lipodystrophy |
| RS786205069 |
BSCL2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 2, Berardinelli-Seip congenital lipodystrophy |
| RS786205070 |
BSCL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital generalized lipodystrophy type 2, Berardinelli-Seip congenital lipodystrophy |
| RS786205071 |
BSCL2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 2, Neuronopathy |
| RS786205073 |
BSCL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital generalized lipodystrophy type 2, Berardinelli-Seip congenital lipodystrophy |
| RS786205074 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS786205076 |
TCAP
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2G, Primary familial hypertrophic cardiomyopathy |
| RS786205077 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS786205078 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS786205080 |
TSHR
|
Health Risk |
Likely pathogenic |
Hypothyroidism due to TSH receptor mutations, Hypothyroidism due to TSH receptor mutations |
| RS786205081 |
DYSF
|
Health Risk |
Pathogenic |
Distal myopathy with anterior tibial onset, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS786205082 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS786205083 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS786205084 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS786205085 |
ADAM9
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 9, Cone-rod dystrophy 9 |
| RS786205086 |
ADAM9
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 9, Cone-rod dystrophy |
| RS786205087 |
PMP22
|
Health Risk |
Pathogenic |
DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT |
| RS786205088 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS786205089 |
IGHMBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS786205090 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS786205091 |
F7
|
Health Risk |
Pathogenic |
Factor VII deficiency, Congenital factor VII deficiency |
| RS786205092 |
BPGM
|
Health Risk |
Pathogenic |
Deficiency of bisphosphoglycerate mutase, Deficiency of bisphosphoglycerate mutase |
| RS786205093 |
PRF1
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 2, Aplastic anemia |
| RS786205094 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS786205095 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS786205096 |
GGCX
|
Health Risk |
Pathogenic |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS786205097 |
TYMP
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS786205098 |
TYMP
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS786205099 |
POR
|
Health Risk |
Pathogenic |
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis |
| RS786205100 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS786205101 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS786205102 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS786205103 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS786205104 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS786205105 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 10, Neuronal ceroid lipofuscinosis 10 |
| RS786205106 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS786205107 |
CYP19A1
|
Health Risk |
Pathogenic |
Aromatase deficiency, Aromatase deficiency |
| RS786205108 |
CYP19A1
|
Health Risk |
Pathogenic |
Aromatase deficiency, Aromatase deficiency |
| RS786205109 |
CYP19A1
|
Health Risk |
Pathogenic |
Aromatase deficiency, Aromatase deficiency |
| RS786205110 |
CYP19A1
|
Health Risk |
Pathogenic |
Aromatase deficiency, Aromatase deficiency |
| RS786205111 |
PMP22
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease |
| RS786205113 |
TRPM1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS786205114 |
WDR19
|
Health Risk |
Pathogenic |
Nephronophthisis 13, Nephronophthisis 13 |
| RS786205115 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS786205116 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS786205117 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS786205118 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS786205119 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS786205120 |
ALOXE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive congenital ichthyosis 3, Autosomal recessive congenital ichthyosis 3 |
| RS786205121 |
KCNV2
|
Health Risk |
Pathogenic |
Cone dystrophy with supernormal rod response, Retinal dystrophy |
| RS786205122 |
LRP2
|
Health Risk |
Pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS786205123 |
ZMPSTE24
|
Health Risk |
Pathogenic |
Lethal tight skin contracture syndrome, Lethal tight skin contracture syndrome |
| RS786205124 |
ROGDI
|
Health Risk |
Pathogenic/Likely pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS786205126 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel syndrome, type 3 |
| RS786205127 |
LRPAP1
|
Health Risk |
Pathogenic |
Myopia 23, autosomal recessive |
| RS786205129 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Intellectual disability |
| RS786205133 |
RLIM
|
Health Risk |
Pathogenic |
Non-syndromic X-linked intellectual disability, Intellectual disability |
| RS786205134 |
ALG9
|
Health Risk |
Conflicting classifications of pathogenicity |
Gillessen-Kaesbach-Nishimura syndrome, Gillessen-Kaesbach-Nishimura dysplasia |
| RS786205135 |
NBN
|
Health Risk |
Pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS786205137 |
CLPB
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria, type VIIB |
| RS786205138 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS786205139 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS786205140 |
CAST
|
Health Risk |
Pathogenic |
Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome, Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome |
| RS786205141 |
CAST
|
Health Risk |
Pathogenic |
Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome, Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome |
| RS786205142 |
SIX6
|
Health Risk |
Likely pathogenic |
Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome, Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome |
| RS786205143 |
DPP6
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 33 |
| RS786205144 |
ACTN2
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1AA, Cardiovascular phenotype |
| RS786205145 |
SDHA
|
Health Risk |
Likely pathogenic |
Carney triad, Carney triad |
| RS786205146 |
SDHC
|
Health Risk |
Pathogenic |
Carney triad, Hereditary cancer-predisposing syndrome |
| RS786205147 |
SDHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Carney triad, Hereditary cancer-predisposing syndrome |
| RS786205148 |
RD3
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 12, Abnormality of the eye |
| RS786205149 |
RD3
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 12, Leber congenital amaurosis 12 |
| RS786205150 |
RD3
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 12, Leber congenital amaurosis 12 |
| RS786205151 |
ADAM9
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 9, Cone-rod dystrophy 9 |
| RS786205155 |
ETV6
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, Acute lymphoid leukemia |
| RS786205156 |
LIPT1
|
Health Risk |
Pathogenic |
Lipoyl transferase 1 deficiency, Lipoyl transferase 1 deficiency |
| RS786205157 |
AARS1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 29 |
| RS786205159 |
SIK1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 30 |
| RS786205160 |
SIK1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 30 |
| RS786205161 |
SIK1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 30 |
| RS786205162 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS786205163 |
SIK1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 30 |
| RS786205164 |
CDK5
|
Health Risk |
Pathogenic |
Lissencephaly 7 with cerebellar hypoplasia, Lissencephaly 7 with cerebellar hypoplasia |
| RS786205165 |
MTOR
|
Health Risk |
Pathogenic |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, CEBALID syndrome |
| RS786205166 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS786205167 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS786205168 |
ERCC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Cockayne syndrome type 2, 7 conditions |
| RS786205169 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS786205170 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cerebrooculofacioskeletal syndrome 1 |
| RS786205171 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cerebrooculofacioskeletal syndrome 1 |
| RS786205172 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cerebrooculofacioskeletal syndrome 1 |
| RS786205173 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS786205174 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, 7 conditions |
| RS786205175 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS786205176 |
ERCC8
|
Health Risk |
Pathogenic |
Cockayne syndrome type 1, Cockayne syndrome type 1 |
| RS786205177 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS786205178 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS786205180 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS786205181 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |
| RS786205182 |
FLNA
|
Health Risk |
Likely pathogenic |
Heterotopia, periventricular |